A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Akeso
Related studies linked through entity extraction aliases.
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
AK104 in Neoadjuvant Treatment of Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of AK112 in Advanced Malignant Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114
- Status
- UNKNOWN
- Phase
- PHASE1
Phase 3 Clinical Study of AK112 for NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of AK119 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2